Zeros, yes, thank you for pointing out that correction. I

New Post Public Reply Private Reply Replies (1) Message Board
EliteYoda ZeroZeros #11830
Zeros, yes, thank you for pointing out that correction. I was confusing RFMK with another stock I have been analyzing recently which had a FYE at the end of March. RFMK does indeed have it's Fiscal Year End on the last day of each year so as for the reporting requirements, the OTC markets will only begin to enforce the new modifications to those existing companies on the OTCQB by way of their statement in the compliance notice,

"OTC Markets will roll out the new procedures for
OTCQB over the course of a year. Each company
will be required to comply with the new OTCQB
procedures 120 days after its Fiscal Year End"

However, this is just for the new procedures regarding reporting requirements.
As for the bid requirement for existing OTCQB stocks, the FYE does not matter. They will begin enforcing the minimum bid requirement ($0.01) starting May 1 2014.

"Beginning May 1, 2014:
Bid Test: All current OTCQB companies that
do not meet the minimum bid test (minimum
bid price of $0.01 per share as of the close of
business for at least one of the previous thirty
consecutive calendar days) will be removed
from OTCQB beginning May 1"

So by the way the new requirements and timing of enforcement are outlined, it appears that the new bid requirement will be RFMK's first hurdle to overcome (May 1). So in conclusion it seems you corrected my erroneous FYE date but I must correct your assumption that RFMK has over a year to "get its stock price up over a penny". I believe that management has a year or so to continue to comply with OTC Markets reporting requirements but as for the bid requirement, I think once May 1 2014 rolls around the bid test will be in effect which means that the prior 30 days of trading are scrutinized such that there needs to be at least one day with a bid of at least $0.01 at the close of session, and then from then on the 30 day window continues to be 30 days in the past from the current day. That is how I interpret the OTC notice but wrong I could be. I guess in a couple weeks we will see what happens. IMO it would be a shame for RFMK to lose it's QB tier just because of a bid requirement but like most of the ongoing new policy adjustments, the changes are just band-aids and typically do not work as intended, meanwhile the real massive holes in the regulations involve the small fines hundreds of firms pay each month for breaking SEC regulations in regard to not fully reporting short sale figures, which is typically a way for the firms to get away with manipulating stock prices with naked short sales and failures to deliver, cellar-boxing and kiting using ex-clearing arrangements. It is a dark cesspool in the OTC scum swamp land and the SEC/FINRA and now the OTC Markets are doing absolutely nothing to actually rectify the issues. All just my own opinions.

GLTA

$RFMK

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 231

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 342

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 423

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

RBC Capital Provides Cautious Outlook on Oracle Corporation

Updated Category News Views 107

RBC Initiates Coverage of Oracle Corporation RBC Capital analysts have recently launched their coverage of Oracle Corporation (NYSE: ORCL) with a Sector Perform rating, setting a price target of $165. This decision comes amidst growing concerns regarding the competitive landscape and the sustainability of Oracle's recent growth initiatives. Concerns Over Competition While...

Continue Reading
Discover the New Coach House Collection by Oakwood Homes

Updated Category News Views 377

Oakwood Homes Introduces the Coach House Collection Today, Oakwood Homes has proudly introduced the new Coach House collection, located in their latest master-planned community. This exciting development enhances the options available for homebuyers seeking affordable and designed living spaces that fit their lifestyle. Details of the Coach House Collection The Coach...

Continue Reading
IDBS Empowers BioPharma with Insights on Lab Data Management

Updated Category News Views 145

Insights into Lab Data Management by IDBS IDBS, a leading global provider of cloud software for BioPharma companies, has recently released insightful findings from their survey on lab data management. This survey captured the views of 856 BioPharma professionals regarding the current challenges and priorities in the field. Key Findings from the Survey The IDBS platform...

Continue Reading
Investigation Launched: Is Adams Resources & Energy Fairly Sold?

Updated Category News Views 441

Investigation into the Sale of Adams Resources & Energy, Inc. Halper Sadeh LLC, a prominent law firm specializing in investor rights, has initiated an investigation into the recent sale of Adams Resources & Energy, Inc. (NYSE: AE). The sale involves an agreement with an affiliate of Tres Energy LLC, with an offer price of $38.00 per share in cash. The main focus of this...

Continue Reading
CLIQ Digital AG's Strategic Move to the Frankfurt Stock Exchange

Updated Category News Views 121

Introduction to CLIQ Digital AG's Transition CLIQ Digital AG has recently announced pivotal changes regarding the trading of its shares. The management team has decided to shift the company's shares to the Basic Board of the open market on the Frankfurt Stock Exchange, marking a significant milestone in its operational strategy. Details of the Transition Following the...

Continue Reading
End -->